Department of Biochemistry and Experimental Medicine, The Children's Memorial Health Institute Warsaw, Poland.
Folia Neuropathol. 2009;47(4):306-13.
Peroxisomal disorders are a large group of genetically determined metabolic diseases in which the biogenesis of peroxisomes is defective or there is a deficiency of only a single enzyme activity or substrate transporter. The objective of this report is to present ten years of experience in the diagnostics of peroxisomal disorders in Poland. Very-long-chain fatty acid (VLCFA) levels as a biomarker for peroxisomal defects were determined by gas chromatography in 1264 subjects with suspicion of peroxisome disease. Peroxisome biogenesis disorders (PBD) were diagnosed in 8 patients, bifunctional protein deficiency in 3 and X-linked adrenoleukodystrophy (X-ALD/AMN) in 127 hemi- or heterozygotes. The frequency of PBD was estimated as 0.20 : 100 000, and that of X-ALD/AMN 2.9 : 100,000 in Poland. Mean total delay time (onset of symptoms and diagnosis) for X-ALD/AMN was 2.2 years (range 0.25-13). High correlation of serum C26:0 concentration and survival for PBD patient (r2 = 0.822; p < 0.001) was found.
过氧化物酶体病是一大组遗传代谢疾病,其过氧化物酶体的生物发生存在缺陷,或者只有单一酶活性或底物转运蛋白缺乏。本报告的目的是介绍波兰在过氧化物酶体疾病诊断方面十年的经验。通过气相色谱法,对 1264 名疑似过氧化物酶体疾病患者的极长链脂肪酸(VLCFA)水平作为过氧化物酶体缺陷的生物标志物进行了测定。在 8 名患者中诊断出过氧化物酶体生物发生障碍(PBD),在 3 名患者中诊断出双功能蛋白缺乏,在 127 名半合子或杂合子中诊断出 X 连锁肾上腺脑白质营养不良(X-ALD/AMN)。波兰 PBD 的发病率估计为 0.20:100000,X-ALD/AMN 的发病率为 2.9:100000。X-ALD/AMN 的平均总延迟时间(症状发作和诊断)为 2.2 年(范围为 0.25-13)。还发现 PBD 患者血清 C26:0 浓度与生存率的高度相关性(r2=0.822;p<0.001)。